Balanced news tone
News Sentiment
LKFT sentiment intelligence
Lakefront Biotherapeutics NV news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
75/100 classification confidence.
directly relevant articles
high-authority source matches
-0.4% over one week, +4.7% over four weeks, trend inactive, and near fair-value range.
What You Need To Know About The Lakefront Biotherapeutics NV (AMS:LKFT) Analyst Downgrade Today
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
What You Need To Know About The Lakefront Biotherapeutics NV (AMS:LKFT) Analyst Downgrade Today
- Tone
- Negative 34/100
- Event
- Analyst action
- Published
- 14 Jul 2026 04:18
- Source
- simplywall.st
[6-K] Lakefront Biotherapeutics NV Current Report (Foreign Issuer) | LKFT SEC Filing - Form 6-K
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Jul 2026 20:33
- Source
- Stock Titan
Lakefront Announces Paulo Fontoura has Resigned from its Board following his Appointment as Global Head of R&D at Sanofi
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Jul 2026 20:01
- Source
- GlobeNewswire
Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 13 Jul 2026 12:30
- Source
- Market source
Lakefront Biotherapeutics (LKFT) Coverage Resumed by Morgan Stanley with $30 Target
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 10 Jul 2026 17:33
- Source
- GuruFocus
Lakefront draws Equal Weight rating at Morgan Stanley (LKFT)
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 10 Jul 2026 16:41
- Source
- Seeking Alpha
Lakefront Biotherapeutics stock coverage resumed at Equalweight by Morgan Stanley
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jul 2026 07:34
- Source
- Investing.com
Madison Avenue lifts Lakefront (NASDAQ: LKFT) ownership above 5% level
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Jun 2026 07:00
- Source
- Stock Titan
Lakefront Receives Transparency Notification from Madison Avenue Partners
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Jun 2026 20:01
- Source
- GlobeNewswire
Form 13G Lakefront Biotherapeutics NV For: 23 June By Investing.com
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Jun 2026 07:00
- Source
- Investing.com Canada
Lakefront Biotherapeutics (ENXTAM:LKFT) Stock After Recent Gains Still A Recovery Opportunity?
- Tone
- Positive 82/100
- Event
- Market update
- Published
- 13 Jun 2026 07:00
- Source
- Market source
Lakefront Biotherapeutics Launches 50 Million Euros Share Repurchase Program
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 09 Jun 2026 20:18
- Source
- MT Newswires
Lakefront Announces Initiation of €50 Million Stock Repurchase Program
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 09 Jun 2026 07:00
- Source
- Market source
Lakefront Biotherapeutics Names Eric Hedrick as Chief Medical Officer
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jun 2026 20:19
- Source
- MT Newswires
Lakefront Appoints Eric Hedrick, MD, as Chief Medical Officer
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jun 2026 20:01
- Source
- GlobeNewswire
Gilead Sciences (GILD), Lakefront Biotherapeutics Acquire Ouro Medicines to Advance Autoimmune Pipeline
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Jun 2026 04:39
- Source
- Insider Monkey
Gilead and Lakefront Biotherapeutics complete $1.68B acquisition of Ouro Medicines
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 05 Jun 2026 07:00
- Source
- grafa.com
Gilead Sciences, Lakefront Complete Ouro Medicines Acquisition
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 04 Jun 2026 20:41
- Source
- MT Newswires
Lakefront Receives Transparency Notification from Bank of America
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 May 2026 07:00
- Source
- Market source
There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 15 May 2026 07:00
- Source
- simplywall.st
Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 May 2026 07:00
- Source
- Market source
Earnings Report: Lakefront Biotherapeutics NV Missed Revenue Estimates By 78%
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- simplywall.st
Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- simplywall.st
Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- Market source
Lakefront Biotherapeutics NV (AMS:LKFT) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 09 May 2026 07:00
- Source
- Market source
LKFT Stock Price and Chart — NASDAQ:LKFT
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 May 2026 11:48
- Source
- TradingView
Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Apr 2026 07:00
- Source
- Market source
Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 Apr 2026 07:00
- Source
- Market source
A Look Back at Biotechnology Stocks’ Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 29 Mar 2026 07:00
- Source
- TradingView